CD38 and periodontal disorder: In this study, we further demonstrated that the inhibition of CD38 by 78c displayed both an anti-inflammatory effect in response to oral pathogens and AGE stimulation and anti-osteoclastogenic properties in response to RANKL stimulation, suggesting that inhibition of CD38 by 78c could become a promising therapeutic strategy for treating periodontal diseases.